Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
Add more filters










Publication year range
1.
Bull Exp Biol Med ; 171(5): 627-632, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34626281

ABSTRACT

Two radiopharmaceutical preparations were developed on the basis of artificial targeted polypeptide ZHER2 specific to HER2/neu tumor marker and radionuclides 177Lu (ZHER2-HSA-chelator-177Lu) or 212Pb (ZHER2-HSA-chelator-212Pb). The objective was to evaluate in vitro the cytotoxic activity of the targeted radiopharmaceuticals using two cultured human breast cancer cell lines with different expression of HER2/neu: SK-BR3 (high expression of HER2/neu) and MCF-7 (low expression of HER2/neu). It was shown that the cytotoxic effect of both preparations was significantly higher against the SK-BR-3 cells. The cytotoxicity correlated with the incubation period (it was higher after 72 h than after 24 h) and was significantly more pronounced in comparison with activity of radionuclide salts without a specific ligand. In vivo preclinical study of these pharmaceuticals seems to be very promising in animals with xenografted tumors showing high expression of HER2/neu marker.


Subject(s)
Antineoplastic Agents/therapeutic use , Breast Neoplasms/radiotherapy , Immunotoxins/therapeutic use , Lead Radioisotopes/therapeutic use , Lutetium/therapeutic use , Radioisotopes/therapeutic use , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Cell Line, Tumor , Female , Humans , Lead Radioisotopes/chemistry , MCF-7 Cells , Molecular Targeted Therapy/methods , Radiopharmaceuticals/therapeutic use , Substrate Specificity
2.
Acta Naturae ; 12(3): 102-113, 2020.
Article in English | MEDLINE | ID: mdl-33173600

ABSTRACT

Today, it has become apparent that innovative treatment methods, including those involving simultaneous diagnosis and therapy, are particularly in demand in modern cancer medicine. The development of nanomedicine offers new ways of increasing the therapeutic index and minimizing side effects. The development of photoactivatable dyes that are effectively absorbed in the first transparency window of biological tissues (700-900 nm) and are capable of fluorescence and heat generation has led to the emergence of phototheranostics, an approach that combines the bioimaging of deep tumors and metastases and their photothermal treatment. The creation of near-infrared (NIR) light-activated agents for sensitive fluorescence bioimaging and phototherapy is a priority in phototheranostics, because the excitation of drugs and/or diagnostic substances in the near-infrared region exhibits advantages such as deep penetration into tissues and a weak baseline level of autofluorescence. In this review, we focus on NIR-excited dyes and discuss prospects for their application in photothermal therapy and the diagnosis of cancer. Particular attention is focused on the consideration of new multifunctional nanoplatforms for phototheranostics which allow one to achieve a synergistic effect in combinatorial photothermal, photodynamic, and/or chemotherapy, with simultaneous fluorescence, acoustic, and/or magnetic resonance imaging.

3.
Mol Biol (Mosk) ; 51(6): 907-926, 2017.
Article in Russian | MEDLINE | ID: mdl-29271956

ABSTRACT

In this review, the authors' works published within the past 5 years devoted to the development of bifunctional hybrid nanostructures based on the targeting polypeptides and nanoparticles of various origin (quantum dots, nanogold, nanodiamonds, upconversion nanoparticles, magnetic and polymer nanoparticles) as modules that ensure visualization and various damaging effects on cancer cells are surveyed and the prospects of their application in theranostics and precision medicine have been contemplated.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Antibodies, Neutralizing/therapeutic use , Antineoplastic Agents, Immunological/therapeutic use , Neoplasms/drug therapy , Protein Engineering/methods , Animals , Antibodies, Bispecific/biosynthesis , Antibodies, Bispecific/genetics , Antibodies, Bispecific/therapeutic use , Antibodies, Monoclonal/biosynthesis , Antibodies, Monoclonal/genetics , Antibodies, Neutralizing/biosynthesis , Antibodies, Neutralizing/genetics , Humans , Immunoconjugates/genetics , Immunoconjugates/metabolism , Immunoconjugates/therapeutic use , Immunotoxins/genetics , Immunotoxins/metabolism , Immunotoxins/therapeutic use , Nanoparticles/therapeutic use , Neoplasms/diagnosis , Neoplasms/immunology , Neoplasms/pathology , Photochemotherapy/methods , Precision Medicine , Quantum Dots/therapeutic use , Theranostic Nanomedicine/methods , Xenograft Model Antitumor Assays
4.
Acta Naturae ; 7(3): 126-32, 2015.
Article in English | MEDLINE | ID: mdl-26483969

ABSTRACT

Design and evaluation of new high-affinity protein compounds that can selectively and efficiently destroy human cancer cells are a priority research area in biomedicine. In this study we report on the ability of the recombinant phototoxic protein DARPin-miniSOG to interact with breast adenacarcinoma human cells overexpressing the extracellular domain of human epidermal growth factor receptor 2 (HER2). It was found that the targeted phototoxin DARPin-miniSOG specifically binds to the HER2 with following internalization and slow recycling back to the cell membrane. An insight into the role of DARPin-miniSOG in HER2 internalization could contribute to the treatment of HER2-positive cancer using this phototoxic protein.

5.
Bioorg Khim ; 41(5): 539-52, 2015.
Article in Russian | MEDLINE | ID: mdl-26762091

ABSTRACT

This mini-review summarizes recent data obtained in the process of creation of a versatile module platform suitable for construction of supramolecular theranostic agents. As an example, we consider multifunctional hybrid agents for imaging and elimination of cancer cells. The use of an adapter protein system barnase:barstar for producing targeted multifunctional hybrid structures on the basis of highly specific peptides and mini-antibodies as addressing modules and recombinant proteins and/or nanoparticles of different nature (quantum dots, nanogold, magnetic nanoparticles, nanodiamonds, upconverting nanophosphores, polymer nanoparticles) as agents visualizing and damaging cancer cells is described. New perspectives for creation of selective and highly effective compounds for theranostics and personified medicine are contemplated.


Subject(s)
Bacterial Proteins/chemistry , Drug Carriers/chemistry , Immunotoxins/chemistry , Nanoparticles/chemistry , Ribonucleases/chemistry , Theranostic Nanomedicine/methods , Bacterial Proteins/pharmacology , Bacterial Proteins/therapeutic use , Biomedical Engineering , Drug Delivery Systems , Humans , Immunotoxins/pharmacology , Immunotoxins/therapeutic use , Molecular Targeted Therapy , Neoplasms/diagnosis , Neoplasms/therapy , Recombinant Proteins/chemistry , Recombinant Proteins/pharmacology , Recombinant Proteins/therapeutic use , Ribonucleases/pharmacology , Ribonucleases/therapeutic use
6.
Acta Naturae ; 6(4): 48-53, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25558394

ABSTRACT

The development of targeted constructs on the basis of photoluminescent nanoparticles with a high photo- and chemical stability and absorption/emission spectra in the "transparency window" of biological tissues is an important focus area of present-day medical diagnostics. In this work, a targeted two-component construct on the basis of upconversion nanophosphors (UCNPs) and anti-tumor 4D5 scFv was developed for selective labeling of tumor cells overexpressing the HER2 tumor marker characteristic of a number of human malignant tumors. A high affinity barnase : barstar (Bn : Bs) protein pair, which exhibits high stability in a wide range of pH and temperatures, was exploited as a molecular adapter providing self-assembly of the two-component construct. High selectivity for the binding of the two-component 4D5 scFv-Bn : UCNP-Bs construct to human breast adenocarcinoma SK-BR-3 cells overexpressing HER2 was demonstrated. This approach provides an opportunity to produce similar constructs for the visualization of different specific markers in pathogenic tissues, including malignant tumors.

7.
Biochemistry (Mosc) ; 77(3): 227-45, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22803941

ABSTRACT

General properties of the family of tyrosine kinase ERBB receptors are considered in connection with their role in the generation of cascades of signal transduction in normal and tumor cells. Causes of acquisition of oncogene features by genes encoding these receptors and their role in tumorigenesis are analyzed. Anti-ERBB monoclonal antibodies approved for therapy are described in detail, and mechanisms of their antitumor activity and development of resistance to them are reviewed. The existing and the most promising strategies for creating and using monoclonal antibodies and their derivatives for therapy of cancer are discussed.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Neoplasms/drug therapy , Oncogene Proteins v-erbB/antagonists & inhibitors , Animals , Humans , Neoplasms/genetics , Neoplasms/metabolism , Oncogene Proteins v-erbB/genetics , Oncogene Proteins v-erbB/metabolism , Signal Transduction
8.
Acta Naturae ; 3(1): 29-47, 2011 Jan.
Article in English | MEDLINE | ID: mdl-22649672

ABSTRACT

Semiconductor quantum dots (QDs) are a new class of fluorophores with unique physical and chemical properties, which allow to appreciably expand the possibilities for the current methods of fluorescent imaging and optical diagnostics. Here we discuss the prospects of QD application for molecular diagnostics of tumors ranging from cancer-specific marker detection on microplates to non-invasive tumor imagingin vivo. We also point out the essential problems that require resolution in order to clinically promote QD, and we indicate innovative approaches to oncology which are implementable using QD.

10.
Acta Naturae ; 1(1): 32-50, 2009 Apr.
Article in English | MEDLINE | ID: mdl-22649585

ABSTRACT

The modular structure and versatility of antibodies enables one to modify natural immunoglobulins in different ways for various clinical applications. Rational design and molecular engineering make it possible to directionally modify the molecular size, affinity, specificity, and immunogenicity and effector functions of an antibody, as well as to combine them with other functional agents. This review focuses on up-to-date methods of antibody engineering for diagnosing and treating various diseases, particularly on new technologies meant to refine the effector functions of therapeutic antibodies.

12.
J Mol Biol ; 295(5): 1119-27, 2000 Feb 04.
Article in English | MEDLINE | ID: mdl-10653691

ABSTRACT

The complementary DNAs of the 12 subunits of fission yeast (Schizosaccharomyces pombe) RNA polymerase II were expressed from strong promoters in Saccharomyces cerevisiae and tested for heterospecific complementation by monitoring their ability to replace in vivo the null mutants of the corresponding host genes. Rpb1 and Rpb2, the two largest subunits and Rpb8, a small subunit shared by all three polymerases, failed to support growth in S. cerevisiae. The remaining nine subunits were all proficient for heterospecific complementation and led in most cases to a wild-type level of growth. The two alpha-like subunits (Rpb3 and Rpb11), however, did not support growth at high (37 degrees C) or low (25 degrees C) temperatures. In the case of Rpb3, growth was restored by increasing the gene dosage of the host Rpb11 or Rpb10 subunits, confirming previous evidence of a close genetic interaction between these three subunits.


Subject(s)
Genetic Complementation Test , RNA Polymerase II/chemistry , RNA Polymerase II/metabolism , Saccharomyces cerevisiae/enzymology , Schizosaccharomyces/enzymology , Conserved Sequence/genetics , Conserved Sequence/physiology , Fungal Proteins/chemistry , Fungal Proteins/genetics , Fungal Proteins/metabolism , Gene Deletion , Gene Dosage , Genes, Fungal/genetics , Genes, Fungal/physiology , Humans , RNA Polymerase II/genetics , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/growth & development , Schizosaccharomyces/genetics , Species Specificity , Suppression, Genetic/genetics , Temperature
13.
Bioorg Khim ; 25(6): 450-63, 1999 Jun.
Article in Russian | MEDLINE | ID: mdl-10505233

ABSTRACT

Full-length cDNAs of four new genes encoding cytoplasmic ribosomal proteins L14 and L20 (large ribosomal subunit) and S1 and S27 (small ribosomal subunit) were isolated and sequenced during the analysis of the fission yeast Schizosaccharomyces pombe genome. One of the Sz. pombe genes encoding translation elongation factor EF-2 was also cloned and its precise position on chromosome I established. A unified nomenclature was proposed, and the list of all known genetic determinants encoding cytoplasmic ribosomal proteins of Sz. pombe was compiled. By now, 76 genes/cDNAs encoding different ribosomal proteins have been identified in the fission yeast genome. Among them, 35 genes are duplicated and three homologous genes are identified for each of the ribosomal proteins L2, L16, P1, and P2.


Subject(s)
Fungal Proteins/genetics , Genes, Fungal , Ribosomal Proteins/genetics , Schizosaccharomyces/genetics , Amino Acid Sequence , Base Sequence , Cloning, Molecular , Molecular Sequence Data , Protein Biosynthesis , Sequence Alignment , Terminology as Topic
14.
Bioorg Khim ; 25(11): 828-37, 1999 Nov.
Article in Russian | MEDLINE | ID: mdl-10645488

ABSTRACT

Analysis of literary data (for Saccharomyces cerevisiae, Caenorhabditis elegans, Arabidopsis thaliana, Homo sapiens, and some other Eucarya) and our data (for Schizosaccharomyces pombe) on the exon-intron organization of the genes encoding subunits of nuclear RNA polymerases showed that introns in the orthologous genes from different organisms are arranged nonrandomly, namely, their positions, if projected on the map of the comparison of the amino acid sequences of the orthologous subunits, not infrequently coincide in evolutionarily distant species. As a rule, intron positions correspond to the boundaries of the structurally conserved regions (domains) or to the sites of possible turns of the polypeptide chain. For example, introns flank the secondary structure elements in the Rpb8 subunit with the known three-dimensional structure or the structure-function modules in subunits Rpb10 and Rpc10. These facts are in agreement with the idea of the ancient origin of introns, and with the notion of evolution of ancient protein sequences through the assembly of their genes from short protoexons selected by the nature as far back as the RNA world times. Comparative analysis of the primary structures of the subunits of eukaryotic RNA polymerases allowed us to reveal a nuclear localization signal in subunit Rpb10 and some hypothetical archaeal homologues of subunit Rpc10.


Subject(s)
Cell Nucleus/enzymology , DNA-Directed RNA Polymerases/genetics , Eukaryotic Cells/enzymology , Evolution, Molecular , Exons , Introns , Amino Acid Sequence , Animals , DNA-Directed RNA Polymerases/chemistry , Humans , Molecular Sequence Data , Sequence Homology, Amino Acid
16.
Bioorg Khim ; 24(1): 42-7, 1998 Jan.
Article in Russian | MEDLINE | ID: mdl-9551201

ABSTRACT

Plasmid pYUK3 bearing the fet5+ gene of Schizosaccharomyces pombe was isolated from a genomic library of the fission yeast, and a detailed physical map of the whole genomic insert (ca. 9.6 Kbp) was constructed. The primary structure of the fet5+ gene and its flanking regions is established. The gene contains a single 45-bp intron in its distal part. A typical TATA-box (TATAAG) was found in the 5'-noncoding region ca. 50 bp upstream of the putative start of transcription, and the 3'-noncoding region contains AT-rich palindromes, which are probably involved in termination of the fet5+ transcription. A previously unidentified gene of Sz. pombe encoding a protein with some similarity to one of the transcriptional activators from the TBP (TATA-binding protein) group of SPT factors of transcription was found in the vicinity of the fet5+ gene. Taking into account that cDNA of the fet5(+)-gene was isolated as a suppressor of the genetic-defect of nuclear RNA polymerases I-III (Bioorg. Khim., 1997, vol. 23, No 3, pp. 234-237), this vicinity may be the first evidence of possible clustering, in the genome of the fission yeast, of genes participating in transcription regulation.


Subject(s)
DNA, Fungal/chemistry , Exons/genetics , Genes, Fungal/genetics , Introns/genetics , Schizosaccharomyces pombe Proteins , Schizosaccharomyces/genetics , Transcription Factors/genetics , Alternative Splicing , Amino Acid Sequence , Base Sequence , DNA, Fungal/genetics , DNA-Directed RNA Polymerases/genetics , Gene Expression Regulation, Fungal/genetics , Genomic Library , Glutamine , Molecular Sequence Data , Plasmids , Polymerase Chain Reaction , Proline , TATA Box , Transcription, Genetic
17.
Bioorg Khim ; 24(11): 877-80, 1998 Nov.
Article in Russian | MEDLINE | ID: mdl-10079944

ABSTRACT

Full-length copies of cDNA of the hRPC11 gene encoding the smallest specific subunit of nuclear RNA polymerase III were identified among human transcripts with the use of the RT-PCR technique. The cloning of the first orthologue of the subunit RPC11 from a multicellular organism and the comparison of subunit hRPC11 of Homo sapiens (108 aa; M(r), 12.3 kDa; pI 8.05) deduced from the cDNA primary structure with the homologous components of RNA polymerase III from Saccharomyces cerevisiae and Schizosaccharomyces pombe revealed the most important functional domains: a Zn-binding motif of the classic type (CxxCx16-17CxxC) at the N-terminal region, and two extended regions of homology (KEVDDVLGG and RSADEPM) in the central and C-terminal parts of the molecule, respectively. The C-terminus of the RPC11 subunits is highly homologous to the unique zinc ribbon of the elongation factor TFIIS, which suggests a role for this subunit in the elongation or termination of RNA synthesis.


Subject(s)
DNA-Directed RNA Polymerases/chemistry , Amino Acid Sequence , Base Sequence , DNA-Directed RNA Polymerases/genetics , Electrophoresis, Agar Gel , Humans , Molecular Sequence Data , Reverse Transcriptase Polymerase Chain Reaction , Zinc Fingers
18.
Bioorg Khim ; 24(2): 119-25, 1998 Feb.
Article in Russian | MEDLINE | ID: mdl-10335407

ABSTRACT

A full-length cDNA of the rpb8+ gene encoding a common subunit Rpb8 of nuclear RNA polymerases I-III only specific for Eucarya was isolated from an expression library of the fission yeast Schizosaccharomyces pombe. The primary structure of the corresponding fragment of the Sz. pombe genome was also established. The rpb8+ gene contains two short introns, 59 and 48 bp long. Only short segments of homology were found upon comparing the Rpb8 subunit homologs from various eukaryotic species, and substantial differences exist between the corresponding proteins of unicellular and multicellular organisms. Subunit Rpb8 of Sz. pombe proved to be the smallest one among the known related proteins: it lacks the 21-aa fragment corresponding to amino acids residues 68-88 of the central part of the homologous subunit ABC14.5 of Saccharomyces cerevisiae. Accordingly, subunit Rpb8 of the fission yeast was not capable of substituting in vivo subunit ABC14.5 in nuclear RNA polymerases of the baker's yeast.


Subject(s)
Genes, Fungal , RNA Polymerase III/metabolism , RNA Polymerase II/metabolism , RNA Polymerase I/metabolism , Schizosaccharomyces/genetics , Amino Acid Sequence , Base Sequence , Cloning, Molecular , DNA, Complementary , Eukaryotic Cells/enzymology , Humans , Molecular Sequence Data , Mutagenesis, Site-Directed , RNA Polymerase I/chemistry , RNA Polymerase I/genetics , RNA Polymerase II/chemistry , RNA Polymerase II/genetics , RNA Polymerase III/chemistry , RNA Polymerase III/genetics , Saccharomyces cerevisiae/genetics , Sequence Homology, Amino Acid
19.
Bioorg Khim ; 23(5): 441-8, 1997 May.
Article in Russian | MEDLINE | ID: mdl-9290054

ABSTRACT

The full-length cDNA of the rpc10+ gene encoding mini-subunit Rpc10, which is common for all three nuclear RNA polymerases of the fission yeast Schizosaccharomyces pombe, was cloned and sequenced. The Rpc10 subunit of Sz. pombe and its homologs from S. cerevisiae and H. sapiens are positively charged proteins with a highly conserved C-terminal region and an invariant zinc-binding domain (Zn-finger) of a typical amino acid composition: YxCx2Cx12RCx2CGxR. Functional tests of heterospecific complementation, using tetrad analysis or plasmid shuffling, showed that the Rpc10 subunit of Sz. pombe can successfully replace the homologous ABC10 alpha subunit in nuclear RNA polymerases I-III of S. cerevisiae.


Subject(s)
DNA-Directed RNA Polymerases/genetics , Fungal Proteins/genetics , Genes, Fungal , Schizosaccharomyces/genetics , Amino Acid Sequence , Base Sequence , Cloning, Molecular , DNA, Complementary/genetics , DNA, Complementary/isolation & purification , Molecular Sequence Data , Sequence Alignment , Sequence Analysis
20.
Bioorg Khim ; 23(3): 234-7, 1997 Mar.
Article in Russian | MEDLINE | ID: mdl-9190794

ABSTRACT

The cDNA of a previously uncharacterized gene fet5 (factor of eukaryotic transcription, clone no. 5) of the fission yeast Schizosaccharomyces pombe was cloned by the heterospecific complementation of a conditional mutant of Saccharomyces cerevisiae defective in the function of the RNA polymerases I-III common subunit ABC10 beta. The gene encodes a new factor of eukaryotic transcription, Fet5, the first member of a superfamily of proteins for which the area of functioning is determined. The Fet5-superfamily consists of three distinct families of proteins highly evolutionarily conserved and widely spread among eukaryotes. Features of the Fet5 amino acid sequence suggest that it belongs to ATP/GTP-binding proteins.


Subject(s)
Schizosaccharomyces/genetics , Transcription Factors/genetics , Amino Acid Sequence , Base Sequence , DNA, Complementary/genetics , Genetic Complementation Test , Molecular Sequence Data , Saccharomyces cerevisiae/genetics , Species Specificity , Transcription Factors/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...